Filing Summary
Helus Pharma Inc. filed a Form 6-K as a foreign private issuer for October 2026. The report was signed on October 8, 2026, by Chief Financial Officer Greg Cavers. The filing identifies the company as a Form 40-F filer.
Financial and Operating Information
The provided filing text contains no financial statements, operating results, cash-flow data, debt or liquidity measures, or comparative-period figures. It therefore does not provide a basis to assess financial performance or changes versus a prior period.
Outlook, Risks and Other Items
The exhibit index lists Exhibit 99.1, a news release dated October 8, 2026, but the news release itself is not included in the provided text. Guidance, management commentary, risks, contingencies, and unusual items are not assessable from this text.
Key Facts to Verify
- Review Exhibit 99.1 for the news release’s substantive announcements and any financial or operational information.
- Consult the company’s relevant financial filings for results, liquidity, debt, and period-over-period comparisons.